Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    20014183 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Silymarin (Milk Thistle Extract) in Treating Patients With Acute Lymphoblastic Leukemia Who Are Receiving Chemotherapy
Conditions: Drug/Agent Toxicity by Tissue/Organ;   Leukemia
Intervention: Dietary Supplement: silymarin

Indicates status has not been verified in more than two years